Callan Capital, LLC Merck & Co., Inc. Transaction History

Callan Capital, LLC

$1.42 Billion
Q3 2024

A detailed history of Callan Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Callan Capital, LLC holds 10,625 shares of MRK stock, worth $1.05 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

10,625

Previous 10,980 3.23%

Holding current value

$1.05 Million

Previous $1.36 Million 11.26%

% of portfolio

0.08%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $39,458 - $45,784	-355 Reduced 3.23%	10,625 $1.21 Million
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $146,950 - $157,823	1,187 Added 12.12%	10,980 $1.36 Million
Q1 2024 Oct 22, 2024	SELL	$113.24 - $131.95 $134,415 - $156,624	-1,187 Reduced 10.81%	9,793 $1.29 Million
Q1 2024 May 03, 2024	BUY	$113.24 - $131.95 $235,199 - $274,060	2,077 Added 26.92%	9,793 $1.29 Million
Q4 2023 Feb 02, 2024	BUY	$100.18 - $109.02 $33,259 - $36,194	332 Added 4.5%	7,716 $841,000
Q3 2023 Nov 06, 2023	BUY	$102.95 - $114.33 $43,444 - $48,247	422 Added 6.06%	7,384 $760,000
Q2 2023 Aug 04, 2023	SELL	$108.61 - $118.38 $123,163 - $134,242	-1,134 Reduced 14.01%	6,962 $803,000
Q1 2023 Jun 13, 2023	BUY	$102.94 - $114.86 $7,720 - $8,614	75 Added 0.94%	8,096 $861,000
Q1 2023 May 08, 2023	BUY	$102.94 - $114.86 $7,720 - $8,614	75 Added 0.94%	8,096 $861,000
Q4 2022 Jun 13, 2023	SELL	$87.44 - $112.11 $6,558 - $8,408	-75 Reduced 0.93%	8,021 $889,000
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $305,690 - $391,936	3,496 Added 77.26%	8,021 $889,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $50,548 - $56,786	598 Added 15.23%	4,525 $390,000
Q1 2022 May 10, 2022	BUY	$73.51 - $82.4 $6,248 - $7,004	85 Added 2.21%	3,927 $322,000
Q4 2021 Jan 21, 2022	BUY	$72.28 - $90.54 $5,782 - $7,243	80 Added 2.13%	3,842 $294,000
Q3 2021 Oct 15, 2021	SELL	$71.68 - $78.83 $7,168 - $7,883	-100 Reduced 2.59%	3,762 $283,000
Q2 2021 Aug 10, 2021	BUY	$70.31 - $77.77 $7,031 - $7,777	100 Added 2.66%	3,862 $300,000
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $238,360 - $330,378	3,762 New	3,762 $289,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.

Account

Callan Capital, LLC Merck & Co., Inc. Transaction History